These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 1364446)
1. [Preliminary screening for antiviral AIDS drugs. III. Report on fiscal year 1990]. Ohtake T; Mori H; Morimoto M; Ueba N; Kunita N; Matsuda Y; Matsuyama M; Akiyoshi K; Noro S; Sato N Eisei Shikenjo Hokoku; 1992; (110):88-91. PubMed ID: 1364446 [TBL] [Abstract][Full Text] [Related]
2. [Preliminary screening for antiviral AIDS drugs. IV. Report on fiscal year 1991]. Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S; Sato N; Sakurada N; Fujita N; Ishizaki T; Kamimura N Eisei Shikenjo Hokoku; 1993; (111):100-2. PubMed ID: 7920545 [TBL] [Abstract][Full Text] [Related]
3. [Preliminary screening for antiviral AIDS drugs. I. Report on fiscal year 1988]. Miki T; Ohnuki N; Shinkai T; Yabuuchi K; Ono T; Ohtomo N; Matsuda Y; Matsuyama M; Akiyoshi K; Ohtake T Eisei Shikenjo Hokoku; 1990; (108):128-31. PubMed ID: 1364341 [TBL] [Abstract][Full Text] [Related]
4. [Preliminary screening for antiviral AIDS drugs. VI. Report for fiscal year 1993]. Ushijima H; Takahashi K; Kunisada T; Moritugu Y; Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S; Sawada H; Sakurada N; Yamada A; Ishizaki T; Kamimura N; Yoshida Y; Ono T; Ohtomo N; Morishita T; Kobayashi S; Miyake T; Ishiwara Y; Suzuki R; Saito T; Etoh S; Mise K Eisei Shikenjo Hokoku; 1996; (114):48-9. PubMed ID: 9037865 [TBL] [Abstract][Full Text] [Related]
5. [Preliminary screening for antiviral AIDS drugs. VII. Report for fiscal year 1994]. Ohmuki N; Kazama K; Sadamasu T; Sekine H; Ohta K; Kudoh Y; Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S; Sawada H; Kimura H; Yamada A; Ishizaki T; Kamimura N; Yoshida Y; Ono T; Tachibana N; Morishita T; Kobayashi S; Miyake T; Ishiwara Y; Ishikawa N; Moritugu Y Eisei Shikenjo Hokoku; 1996; (114):50-2. PubMed ID: 9037866 [TBL] [Abstract][Full Text] [Related]
6. [Preliminary screening for antiviral AIDS drugs. IV. Report on fiscal year 1992]. Sekine H; Ohnuki N; Sadamasu K; Ohta K; Terayama T; Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S Eisei Shikenjo Hokoku; 1994; (112):131-3. PubMed ID: 8854914 [TBL] [Abstract][Full Text] [Related]
7. [Preliminary screening for antiviral AIDS drugs. II. Report on fiscal year 1989]. Noro S; Sato N; Sakurada N; Fujita N; Ishizaki T; Kamimura N; Yoshida Y; Ono T; Ohtomo N; Matsuda Y Eisei Shikenjo Hokoku; 1991; (109):107-10. PubMed ID: 1364373 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary screening for antiviral AIDS drugs. VIII. Report for fiscal year 1995]. Morishita T; Kobayashi S; Sato K; Sakae K; Ishikawa N; Kobayashi N; Noguchi Y; Akiyoshi K; Suga T; Ogawa A; Noro S; Sawada H; Kimura H; Yamada A; Ishizaki T; Kamimura N; Iwashima A; Ono T; Tachibana N; Sekine H; Ohnuki N; Kazama K; Sadamasu K; Ohta K; Mise K Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):152-4. PubMed ID: 9641832 [TBL] [Abstract][Full Text] [Related]
9. Rapid screening of antiretroviral combinations. St Clair M; Pennington KN; Rooney J; Barry DW J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S24-7. PubMed ID: 8595504 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 group O sensitivity to antiretroviral drugs. Descamps D; Collin G; Loussert-Ajaka I; Saragosti S; Simon F; Brun-Vézinet F AIDS; 1995 Aug; 9(8):977-8. PubMed ID: 7576340 [No Abstract] [Full Text] [Related]
11. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors. Blair WS; Isaacson J; Li X; Cao J; Peng Q; Kong GF; Patick AK Antiviral Res; 2005 Feb; 65(2):107-16. PubMed ID: 15708637 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT). Balagopala MI; Ollapally AP; Lee HJ Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S1-7. PubMed ID: 8574137 [TBL] [Abstract][Full Text] [Related]
14. Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors. Westby M; Nakayama GR; Butler SL; Blair WS Antiviral Res; 2005 Sep; 67(3):121-40. PubMed ID: 16112209 [TBL] [Abstract][Full Text] [Related]
15. [In vitro effectiveness of new antiviral substances. 1. Results of screening studies against selected picornaviruses]. Tonew M; Tonew E Virologie; 1985; 36(2):103-9. PubMed ID: 2994288 [TBL] [Abstract][Full Text] [Related]
16. Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by ddCyd and ddIno. Ayisi NK East Afr Med J; 1995 Oct; 72(10):654-7. PubMed ID: 8904046 [TBL] [Abstract][Full Text] [Related]
18. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro. Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil against HIV-1. Maruyama T; Kozai S; Demizu Y; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E Nucleic Acids Symp Ser (Oxf); 2004; (48):3-4. PubMed ID: 17150449 [TBL] [Abstract][Full Text] [Related]
20. [Micromethod evaluation of the in vitro sensitivity of ocular herpes strains to antiviral drugs]. Langlois M; Rassat S; Denis J; Aymard M Pathol Biol (Paris); 1983 Jun; 31(6):555-9. PubMed ID: 6348670 [No Abstract] [Full Text] [Related] [Next] [New Search]